As a large, well performing company with an existing syndicate and in a strong sector and jurisdiction, BSN had long been expected to be a blowout. Some loan investors had expressed concern about BSN’s leverage when the deal was launched, saying syndication may not be so straightforward. But
...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
